E30 SEM. O.C. Disclosed Is a Compound Represented by the Formula (1) (51) Int

E30 SEM. O.C. Disclosed Is a Compound Represented by the Formula (1) (51) Int

USOO9453000B2 (12) United States Patent (10) Patent No.: US 9.453,000 B2 Kimura et al. (45) Date of Patent: *Sep. 27, 2016 (54) POLYCYCLIC COMPOUND (56) References Cited (75) Inventors: Teiji Kimura, Tsukuba (JP); Noritaka U.S. PATENT DOCUMENTS Kitazawa, Tsukuba (JP); Toshihiko 3,470,167 A 9, 1969 Sarkar Kaneko, Tsukuba (JP); Nobuaki Sato, 3,989,816 A 1 1/1976 Rajadhyaksha Tsukuba (JP); Koki Kawano, Tsukuba 4,910,200 A 3, 1990 Curtze et al. (JP): Koichi Ito, Tsukuba (JP); 5,281,626 A 1/1994 Oinuma et al. M s Tak ishi Tsukub JP 5,563,162 A 10, 1996 Oku et al. amoru Takaishi Tsukuba (JP); 5,804,577 A 9, 1998 Hebeisen et al. Takeo Sasaki, Tsukuba (JP); Yu 5,985,856 A 11/1999 Stella et al. Yoshida, Tsukuba (JP); Toshiyuki 6,235,728 B1 5, 2001 Golik et al. Uemura, Tsukuba (JP); Takashi Doko, g R 1939. E. al. Its SE E. Shinmyo, 7,138.414 B2 11/2006 Schoenafingereatch et al. et al. sukuba (JP); Daiju Hasegawa, 7,300,936 B2 11/2007 Parker et al. Tsukuba (JP); Takehiko Miyagawa, 7,314,940 B2 1/2008 Graczyk et al. Hatfield (GB); Hiroaki Hagiwara, 7,618,960 B2 11/2009 Kimura et al. Tsukuba (JP) 7,667,041 B2 2/2010 Kimura et al. 7,687,640 B2 3/2010 Kimura et al. 7,713,993 B2 5/2010 Kimura et al. (73) Assignee: EISAI R&D MANAGEMENT CO., 7,737,141 B2 6/2010 Kimura et al. LTD., Tokyo (JP) 7,880,009 B2 2/2011 Kimura et al. 7,897,632 B2 3/2011 Kimura et al. (*) Notice: Subject to any disclaimer, the term of this 7,935,815 B2 5/2011 Kimura et al. patent is extended or adjusted under 35 SS R: 38H SA U.S.C. 154(b) by 1597 days. 8,048,878www. B2 11/2011 KimuraUa et al.a This patent is Subject to a terminal dis- 2001/0051642 A1 12/2001 Ahn et al. claimer. 2002/O128263 A1 9, 2002 Mutel et al. (Continued) (21) Appl. No.: 12/671,873 FOREIGN PATENT DOCUMENTS (22) PCT Filed: Aug. 28, 2008 CN 1668593. A 9, 2005 (86). PCT No.: PCT/UP2008/065.365 DE 3541716 A1 5, 1987 S 371 (c)(1), (Continued)Continued (2), (4) Date: Sep. 23, 2010 OTHER PUBLICATIONS (87) PCT Pub. No.: WO2009/028588 Communication pursuant to Article 94(3) EPC issued Jul. 30, 2013 in European Patent Application No. 05743758.4. PCT Pub. Date: Mar. 5, 2009 (Continued) (65) Prior Publication Data US 2011 FOOO9619 A1 Jan. 13, 2011 Primary Examiner — Susanna Moore (74) Attorney, Agent, or Firm — Birch, Stewart, Kolasch & (30) Foreign Application Priority Data Birch, LLP Aug. 31, 2007 (JP) ................................. 2007-225045 (57) ABSTRACT E30 SEM. O.C. Disclosed is a compound represented by the formula (1) (51) Int. Cl. (I) CO7D 47L/04 (2006.01) A6 IK 3/437 (2006.01) G) ()-X-G) CO7D 487/04 (2006.01) CO7D 49.8/04 (2006.01) CO7D 403/0 (2006.01) or a pharmacologically acceptable salt thereof, which is A61 P 25/28 (2006.01) effective as a therapeutic or prophylactic agent for a disease CO7D 403/04 (2006.01) induced by AB, wherein Ari represents an imidazolyl group (52) U.S. Cl. which may be substituted with a C1-6 alkyl group, or the CPC ........... C07D 403/10 (2013.01); C07D 471/04 like; Ara represents a phenyl group which may be substituted (2013.01); C07D 487/04 (2013.01); C07D with a C1-6 alkoxy group, or the like: X represents a double 498/04 (2013.01) bond, or the like; and Het represents a triazolyl group or the (58) Field of Classification Search like which may be substituted with a C1-6 alkyl group or the CPC ........................... A61K 31/437; C07D 471/04 like, or the like. USPC ........................................... 544/112: 514/299 See application file for complete search history. 4 Claims, No Drawings US 9,453,000 B2 Page 2 (56) References Cited JP 2007-523903. A 8, 2007 JP 2011-506335 A 3, 2011 U.S. PATENT DOCUMENTS JP 2012-51806 A 3, 2012 JP 52.10152 B2 6, 2013 2002/0183324 A1 12/2002 Jacobson et al. RU 2001 126135 A 7, 2003 2003. O195201 A1 10, 2003 Bo et al. TW 379224 B 1, 2000 2003/0208082 A1 11, 2003 Mutel et al. TW 20040O824 1, 2004 2003,0225070 A1 12, 2003 Mutel et al. UZ 4 136 C 4/2010 2004/0006062 A1 1/2004 Smallheer et al. UZ 4 225 C 9, 2010 2004/0034096 A1 2/2004 Jolidon et al. WO WO 87,02587 A1 5, 1987 2004/0038969 A1 2/2004 Doherty et al. WO WO 91/12237 A1 8/1991 2004/0063770 A1 4, 2004 Ahn et al. WO WO95/21832 A1 8/1995 2004/0087798 A1 5, 2004 Yamada WO WO 96,105.59 A1 4f1996 2004/O127494 A1 7, 2004 Parker et al. WO WO 97,14417 A1 4f1997 2004/O127555 A1 7, 2004 Snow et al. WO WO 97/43287 A1 11, 1997 2004/0152743 A1 8/2004 Schoenafinger et al. WO WO 98.03166 A1 1, 1998 2004/0192743 A1 9/2004 Malli et al. WO WO 98.09963 A1 3/1998 2004/0235864 A1 11/2004 Graczyk et al. WO WO 98.24785 A1 6, 1998 2005/0070538 A1 3/2005 Cheng et al. WO WO 98,46605 A1 10, 1998 2005/0085509 A1 4/2005 Takahashi et al. WO WOOOO7993 A1 2/2000 2005, 0131043 A1 6, 2005 Mutel et al. WO WOOO, SO391 A1 8/2000 2005/0187277 A1 8/2005 Malli et al. WO WOOOf 51981 A1 9, 2000 2006/0004013 A1 1/2006 Kimura et al. WO WO O1? 68585 A1 9, 2001 2007/0117798 A1 5, 2007 Kimura et al. WO WO 01/81312 A2 11/2001 2007/0117839 A1 5, 2007 Kimura et al. WO WO O2/4616.6 A1 6, 2002 2007/0219181 A1 9, 2007 Kimura et al. WO WO O3,O22273 A1 3f2003 2007/0249833 A1 10/2007 Cheng et al. WO WO O3,O27081 A2 4, 2003 2008/0070902 A1 3f2008 Kimura et al. WO WO O3,053912 A1 T 2003 2008/0085894 A1 4, 2008 Parker et al. WO WO O3,062206 A2 7, 2003 2008/00968.92 A1 4/2008 Cheng et al. WO WO O3,O74497 A1 9, 2003 2008/0280948 A1 11/2008 Baumann et al. WO WO O3,O82292 A1 10, 2003 2009/0048213 A1 2/2009 Kimura et al. WO WO O3,101927 A1 12/2003 2009/0048448 A1 2/2009 Kushida et al. WO WO 2004/OO2478 A1 1/2004 2009/020391.6 A1 8/2009 Kushida et al. WO WO 2004/OO7429 A1 1/2004 2009/0270623 A1 10, 2009 Shimomura et al. WO WO 2004/OO7455 A1 1/2004 2011/006.5696 A1 3f2011 Kimura et al. WO WO 2004/041776 A2 5, 2004 2011/0086860 Al 4/2011 Kimura et al. WO WO 2004/071447 A2 8, 2004 2011/0275822 A1 11/2011 Minamisono et al. WO WO 2004/089868 A1 10, 2004 2012/0135981 A1 5, 2012 Wu et al. WO WO 2004f1 10350 A2 12/2004 WO WO 2005/020921 A2 3, 2005 WO WO 2005/063754 A1 T 2005 FOREIGN PATENT DOCUMENTS WO WO 2005/072731 A 8, 2005 WO WO 2005/08O346 A1 9, 2005 EP O2 19756 A1 4, 1987 WO WO 2005/087767 A1 9, 2005 EP O 270 091 A1 6, 1988 WO WO-2005.115990 A1 12/2005 EP O 589 491 A1 3, 1994 WO WO 2006/018662 A2 2/2006 EP 1264.820 A1 12/2002 WO WO 2006/046575 A1 5, 2006 EP O973768 B1 7, 2003 WO WO 2006/112550 A2 10, 2006 EP 1757,591 A1 2/2007 WO WO-2007/034282 A2 3, 2007 E. s A. 58. WO WO 2007/060810 A1 5, 2007 WO WO 2007/060821 A1 5, 2007 EP 1953158 A1 8, 2008 WO WO-2007/102580 A1 9, 2007 EP 1992 618 A1 11, 2008 WO WO 2008/O13213 A1 1/2008 EP 2 181992 A1 5, 2010 WO WO-2008/097538 A1 8/2008 EP 2261 218 A2 12/2010 WO WO 2008,1371O2 A2 11/2008 GE P-2006-3920 B 5, 2006 WO WO 2008,137139 A1 11, 2008 GE P-2008-4571 B 12/2008 WO WO 2008,156580 A1 12/2008 JP 52-1035 A 1, 1977 WO WO 2009/020580 A1 2/2009 JP 60-174781. A 9, 1985 WO WO 2009,073777 A1 6, 2009 E. 3-295; A. 32 WO WO 2010/025.197 A1 3f2010 WO WO 2010-097372 A1 9, 2010 JP 8-283219 A 10, 1996 WO WO 2010-097395 A1 9, 2010 JP 9-132578 A 5, 1997 WO WO 2010/098466 A1 9, 2010 JP 10-510512. A 10, 1998 WO WO 2010/098495 A1 9, 2010 JP 11-228548 A 8, 1999 JP 11-5.13686 A 11, 1999 JP 3176365 B2 6, 2001 OTHER PUBLICATIONS JP 2001-508767 A 7, 2001 JP 2001-527083. A 12/2001 First Examination Report issued Jun. 10, 2013 in Indian Patent JP 2003-206280 A 7, 2003 Application No. 4097/DELP/2008. JP 2004-520292 A 7, 2004 -- JP 2004-531519 A 10, 2004 First Examination Report issued Jun. 17, 2013, in Indian Patent JP 2004-536084 A 12, 2004 Application No. 411 1/DELP/2008. JP 2005-518371 A 6, 2005 Notice Before Allowance issued Aug.

View Full Text

Details

  • File Type
    pdf
  • Upload Time
    -
  • Content Languages
    English
  • Upload User
    Anonymous/Not logged-in
  • File Pages
    198 Page
  • File Size
    -

Download

Channel Download Status
Express Download Enable

Copyright

We respect the copyrights and intellectual property rights of all users. All uploaded documents are either original works of the uploader or authorized works of the rightful owners.

  • Not to be reproduced or distributed without explicit permission.
  • Not used for commercial purposes outside of approved use cases.
  • Not used to infringe on the rights of the original creators.
  • If you believe any content infringes your copyright, please contact us immediately.

Support

For help with questions, suggestions, or problems, please contact us